The US Patent and Trademark Office (USPTO) has granted a patent to Nanomix's patent application relating to flexible nanostructure electronic devices, such as nanotube sensors and transistors, and method for fabricating.
The patent allows the company to commercially exploit proprietary carbon nanotube (CNT) technology and other nanostructures to develop point of care (POC) in-vitro diagnostics, including a design for the Omega-3 Cardiac panel.
Cardiac panel, which is currently in initial clinical studies, is designed to perform multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample.
The compact size of the electronic and credit card-sized disposable test cartridge can be configured to run a various tests from range of patient samples.
